Upgrade to SI Premium - Free Trial

UCB to acquire Neurona Therapeutics for up to $1.15 billion

April 17, 2026 2:00 PM
UCB (Euronext Brussels: UCB) announced it has entered into a definitive agreement to acquire Neurona Therapeutics, a clinical-stage biotherapeutics company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions

Next Articles